Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Majid, Dewan S A ^a   Nishiyama, Akira ^a,b   Jackson, Keith E ^a   Castillo, Alexander ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

N nitro L arginine; Renal hemodynamics; Sodium excretion; Superoxide dismutase mimetic; Tempol

Indexed keywords

8 ISOPROSTANE; ISOPROSTANE DERIVATIVE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIURESIS; DOG; ENZYME INHIBITION; FEMALE; GLOMERULUS FILTRATION RATE; HYPOTHESIS; KIDNEY BLOOD FLOW; KIDNEY CELL; KIDNEY FUNCTION; MALE; MICTURITION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SODIUM EXCRETION;

ANIMALS; CYCLIC N-OXIDES; DOGS; ENZYME INHIBITORS; FEMALE; ISOPROSTANES; KIDNEY; MALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; NITROARGININE; RENAL CIRCULATION; SPIN LABELS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 3042700139     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00073.2004     Document Type: Article

References (36)

1. Baud L and Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol Renal Fluid Electrolyte Physiol 251: F765-F776, 1986.
2. Beckman JS and Crow JP. Pathological implications of nitric oxide, superoxide, and peroxinitrite formation. Biol Soc Transact 21: 330-334, 1993.
3. Cannon RO III. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 44: 1809-1819, 1998.
4. 2 counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 285: R827-R833, 2003.
5. Commoner B, Townsend J, and Pake GE. Free radicals in biological materials. Nature 174: 689-691, 1954.
6. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
7. Fridovich I. The biology of oxygen radicals. Science 201: 875-880, 1978.
8. Gorbunov NV, Osipov AN, Day BW, Zayas-Rivera B, Kagan VE, and Elsayed NM. Reduction of ferrylmyoglobin and ferrylhemoglobin by nitric oxide: a protective mechanism against ferryl hemoprotein-induced oxidations. Biochemistry 34: 6689-6699, 1995.
9. Hahn SM, Sullivan FJ, Deluca AM, Bacher JD, Liebmann Krisna MC, Coffin D, and Mitchell JB. Hemodynamic effect of the nitroxide superoxide dismutase mimetics. Free Radic Biol Med 27: 529-535, 1999.
10. Halliwell B, Zhao K, and Whiteman M. Nitric oxide, and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 31: 651-669, 1999.
11. PHOX subunit of NAD(P)H oxidase. Hypertension 43: 1-6, 2004.
12. Huie RE and Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199, 1993.
13. Ichikawa I, Kiyama S, and Yoshioka T. Renal antioxidant enzymes: their regulation and function. Kidney Int 45: 1-9, 1994.
14. Jou SB and Cheng JT. The role of free radicals in the release of noradrenaline from myenteric nerve terminals of guinea-pig ileum. J Auton Nerv Syst 66: 126-130, 1997.
15. Karim F, Majid DSA, and Summerill RA. Sympathetic nerves in the mediation of renal response to localized stimulation of atrial receptors in anesthetized dogs. J Physiol 417: 63-78, 1989.
16. Majid DS and Nishiyama A. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs. Hypertension 39: 293-297, 2002.
17. Majid DSA, Omoro SA, Chin SY, and Navar LG. Intrarenal nitric oxide activity and pressure natriuresis in anesthetized dogs. Hypertension 32: 266-272, 1998.
18. Mason RB, Pluta RM, Walbridge S, Wink DA, Oldfield EH, and Boock RJ. Production of reactive oxygen species after reperfusion in vitro and in vivo: protective effect of nitric oxide. J Neurosurg 93: 99-107, 2000.
19. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, and Roberts LJ II. A series of prostaglandins F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-9387, 1990.
20. O'Donnell VB, Chumley PH, Hogg N, Bloodsworth A, Darley-Usmar VM, and Freeman BA. Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with α-tocopherol. Biochemistry 36: 15216-15223, 1997.
21. Omar HA, Cherry PD, Mortelliti MP, Burke-Wolin T, and Wolin MS. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation. Circ Res 69: 601-608, 1991.
22. Ortiz PA and Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol Renal Physiol 283: F957-F962, 2002.
23. Practico D, Lawson JA, Roakach J, and FitzGerald GA. The isoprostanes in biology and medicine. Trends Endocrinol Metab 12: 243-247, 2001.
24. Romero JC and Rackelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34: 943-949, 1999.
25. Rubanyi GM and Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H822-H827, 1986.
26. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, and Freeman BA. Nitric oxide regulation of superoxide and peroxynitrite- dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269: 26066-26075, 1994.
27. Schnackenberg CG, Welch WJ, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension 32: 59-64, 1998.
28. 2α. Hypertension 33: 424-428, 1999.
29. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106, 1989.
30. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, and Abey Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
31. Vanhouttee PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension 13: 658-667, 1989.
32. Welch WJ, Tojo A, and Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol 278: F769-F776, 2000.
33. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, Westfelt UN, Petersson AS, and Waagstein F. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73: 1121-1127, 1993.
34. Wilcox CS and Welch WJ. Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol Scand 168: 119-124, 2000.
35. Wolin MS, Gupte SA, lesaki T, and Mohazzab-HKM. Oxidant and vascular nitric oxide signalling. In: Nitric Oxide and the Regulation of the Peripheral Circulation, edited by Kadowitz PJ and McNamara DB. Boston, MA: Birkhauser, 2000, p. 33-48.
36. Zou AP, Li N, and Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension 37: 547-553, 2001.